Stocktoria
Phio Pharmaceuticals Corp. PHIO
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2012-05-10
Phio Pharmaceuticals Corp. statistics & valuation
Market cap$11.3M
P / B0.6×
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Return on assets | -40.5% | -124.6% | -115.6% | -89.6% | -52.8% |
| Return on equity | -43.2% | -151.4% | -140.1% | -105.9% | -60.6% |
| Debt / equity | — | — | — | — | 0.00× |
| Current ratio | — | 5.65 | 5.71 | 6.42 | 8.06 |
Source: SEC EDGAR filings · CIK 0001533040 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.